Drawing for CEBREO

USPTO serial 79445174

CEBREO

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
GULIANO, ROBERT N
Law office
TMEG LAW OFFICE 105

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with CEBREO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Electronic systems and apparatus for sensing, acquiring, recording, processing, storing, analyzing, transmitting and streaming physiological data; electronic systems and apparatus for sensing, acquiring, recording, processing, storing, analyzing, transmitting physiological data including electroencephalography (EEG) data, electromyographic (EMG) data, electrocardiographic (ECG) data, photoplethysmography (PPG) data, acoustic data, respiratory data, blood oxygen saturation (SpO2) data, movement data, temperature data and skin conductance data; wearable electronic devices for measuring physiological signals; wearable physiological-signal sensors and data-acquisition units, for sensing, acquiring, recording, processing, storing, analyzing and transmitting physiological data including electroencephalography (EEG) data, electromyographic (EMG) data, electrocardiographic (ECG) data, photoplethysmography (PPG) data, acoustic data, respiratory data, blood oxygen saturation (SpO2) data, movement data, temperature data and skin conductance data; wearable sensor bands, patches, or earpieces for measuring physiological signals; wearable sensor bands, patches, or earpieces for measuring physiological signal data including electroencephalography (EEG) data, electromyographic (EMG) data, electrocardiographic (ECG) data, photoplethysmography (PPG) data, acoustic data, respiratory data, blood oxygen saturation (SpO2) data, movement data, temperature data and skin conductance data; computer hardware and downloadable software for monitoring, analyzing, and displaying physiological data; signal processing units, data acquisition systems, and wireless transmitters for physiological signals; downloadable software for receiving, monitoring, storing, analyzing, visualizing, transmitting and streaming, physiological data including electroencephalography (EEG)data, electromyographic (EMG) data, electrocardiographic (ECG) data, photoplethysmography (PPG) data, acoustic data, respiratory data, blood oxygen saturation (SpO2) data, movement data, temperature data and skin conductance data; downloadable mobile software for creating, recording, managing, and exporting user questionnaires and diaries related to physiological monitoring sessions; communication hubs and relay devices for wireless transmission and streaming of physiological signals to external systems; software for enabling interactive data review, annotation, scoring, and hybrid manual/automated analysis of physiological data for research and diagnostic purposes; software for study management, including participant data tracking, metadata management, and study protocol administration.ACTIVE—
010Medical systems, apparatus and instruments for the acquisition, recording, processing, storing, transmitting or streaming of physiological signal data for diagnostic, monitoring and screening purposes, including electroencephalography (EEG) data, electromyographic (EMG) data, electrocardiographic (ECG) data, photoplethysmography (PPG) data, acoustic data, respiratory data, blood oxygen saturation (SpO2) data, movement data, temperature data, biometric signal data and skin conductance data; wearable medical systems, apparatus and instruments for the acquisition, recording, processing, storing, transmitting or streaming of physiological signals for diagnostic, monitoring and screening purposes use, including electroencephalography (EEG) data, electromyographic (EMG) data, electrocardiographic (ECG) data, photoplethysmography (PPG) data, acoustic data, respiratory data, blood oxygen saturation (SpO2) data, movement data, temperature data and skin conductance data; medical devices and sensors for monitoring heart rate, pulse, brain waves, respiration, oxygen, motion, electrocardiogram and glucose; medical accessories for wearable monitoring devices, namely reusable and disposable electrode arrays, adhesive patches, sensor bands and earpieces for physiological signal acquisition; physiological signal sensors for medical use, namely photoplethysmography (PPG) sensors, temperature sensors, and stethoscope microphones analyte sensors; medical hubs and relay devices for wireless transmission and streaming of physiological signals to external systems; medical alert systems for generating or supporting alerts to patients or healthcare personnel based on physiological signal monitoring; electromyography and stimulation sensors for medical use; wearable monitors and sensors used to measure biometric data for medical use; wearable monitors and sensors used to measure monitoring heart rate, pulse, brain waves, respiration, oxygen, motion, electrocardiogram and glucose; medical testing apparatus for non-invasive physiological monitoring including neurological, cardiovascular, respiratory and metabolic indications and activities; wearable medical testing systems for non-invasive physiological electroencephalography monitoring including neurological, cardiovascular, respiratory and metabolic indications and activities applicable to including epilepsy, sleep disorders, neurodegenerative diseases, migraine, depression, stress, and hypoglycemia.ACTIVE—
042Scientific and technological services, namely, design and development of wearable neurotechnology and biosensing systems; research and development consultancy in the fields of medical devices, physiological monitoring systems, sensor integrations, and medical algorithms, including hardware and software development for third parties; cloud-based data storage and management for physiological data monitoring, including electrophysiological, cardiovascular, respiratory, temperature, acoustic, and movement data, accessible via web-based interfaces; cloud-based software for physiological signal processing, signal quality analysis, data synchronization, event detection, and data annotation, including epilepsy and sleep disorder analysis; providing online non-downloadable software for enabling interactive data review, annotation, scoring, and hybrid manual/automated analysis of physiological data for research and diagnostic purposes; providing online non-downloadable software for study management, including participant data tracking, metadata management, and study protocol administration; software as a service (SaaS) for processing, analyzing, and visualizing physiological signals, including automated data processing and algorithmic analysis for neurological, cardiovascular, and general patient monitoring purposes; providing cloud-based platform for the collection, storage, processing, quality analysis and remote access to physiological data; providing temporary use of non-downloadable software for monitoring of physiological parameters including vital signs monitoring; software for remote patient monitoring, including data transmission, data visualization, and communication between patients and healthcare providers; research and development services in the fields of neuroscience, biosensing, and wearable technology; cloud-based systems for data analysis, pattern recognition, and alert generation based on physiological data, including neurological, cardiovascular, and metabolic indicators; remote neurological assessment services using electroencephalography (EEG) and other physiological signal data for research purposes.ACTIVE—
044Medical and health monitoring services using wearable neurotechnology and biosensing devices including teal-time and retrospective data analysis; remote neurological assessment services using electroencephalography (EEG) and other physiological signal data for clinical purposes; providing health information based on analysis of brain activity, cardiovascular, and respiratory parameters; telemedicine services utilizing wearable devices for real-time monitoring of neurophysiological and physiological conditions; Health wellness and neurofeedback services based on brainwave and biometric signal interpretation; Medical data annotation and scoring services for physiological data, excluding medical and diagnostic purposes, provided as a non-software-based service for research, academic, or data analysis purposes; telemedicine and remote patient monitoring services utilizing wearable neurotechnology and biosensing devices for real-time and retrospective acquisition, transmission, analysis, and interpretation of physiological data and conditions; medical data interpretation services for physiological monitoring data, including electroencephalography (EEG), electromyographic (EMG), electrocardiographic (ECG), photoplethysmographic (PPG), and other physiological signals; manual review, annotation, and scoring of physiological data to support clinical diagnostics, including hybrid manual/automated scoring for epilepsy, sleep disorders, and neurological assessments; medical reporting services, including preparation of diagnostic reports based on physiological monitoring data and data annotation outcomes; consultation services in the field of physiological monitoring data interpretation, including analysis of neurological, cardiovascular, and metabolic indicators; clinical support services for long-term patient monitoring, including seizure detection, sleep analysis, and other condition-specific assessments.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 4, 2026RFNTREFUSAL PROCESSED BY IB—
May 21, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 21, 2026RFRRREFUSAL PROCESSED BY MPU—
Apr 2, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2026DOCKASSIGNED TO EXAMINER—
Mar 5, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 5, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance